BACKGROUND: Several studies indicate that interstitial and intracapillary monocytes/macrophages (MO) represent a significant proportion of graft-infiltrating cells in renal allografts and that their presence may unfavourably affect clinical outcome. Much less is known about the role of MO in vascular rejection of transplanted kidneys. The aim of our study was to determine the cellular composition of immune cell infiltrates in intimal arteritis and to analyse whether it is associated with features of humoral immunity and impaired graft survival. METHODS: In 34 recipients with vascular rejection, we determined the proportion of intimal and interstitial MO and T-cells (expressed as ratio of CD68- and CD3-positive cells) in immunohistochemically double-labelled slides. RESULTS: Intimal arteritis is always composed of T-cells and MO with a median CD68/CD3 ratio of 1.03. In 47% of cases, however, T-cells predominate (CD68/CD3 ratio <1). The median interstitial CD68/CD3 ratio is 0.61, with T-cells dominating in 64% of cases. There is no correlation between the cellular composition of arterial and interstitial infiltrates. The proportion of interstitial and arterial MO has no impact on graft survival, and is, in contrast to previous reports on MO in allograft glomerulitis and capillaritis, not associated with C4d staining. CONCLUSIONS: Intimal arteritis in kidney allograft rejection is composed of a mixed infiltrate of MO and T-lymphocytes. In contrast to MO in PTCitis and glomerulitis, the MO in intimal arteritis are not associated with markers of humoral immune response and there are no different allograft outcomes between MO and T-lymphocyte-dominated groups.
BACKGROUND: Several studies indicate that interstitial and intracapillary monocytes/macrophages (MO) represent a significant proportion of graft-infiltrating cells in renal allografts and that their presence may unfavourably affect clinical outcome. Much less is known about the role of MO in vascular rejection of transplanted kidneys. The aim of our study was to determine the cellular composition of immune cell infiltrates in intimal arteritis and to analyse whether it is associated with features of humoral immunity and impaired graft survival. METHODS: In 34 recipients with vascular rejection, we determined the proportion of intimal and interstitial MO and T-cells (expressed as ratio of CD68- and CD3-positive cells) in immunohistochemically double-labelled slides. RESULTS: Intimal arteritis is always composed of T-cells and MO with a median CD68/CD3 ratio of 1.03. In 47% of cases, however, T-cells predominate (CD68/CD3 ratio <1). The median interstitial CD68/CD3 ratio is 0.61, with T-cells dominating in 64% of cases. There is no correlation between the cellular composition of arterial and interstitial infiltrates. The proportion of interstitial and arterial MO has no impact on graft survival, and is, in contrast to previous reports on MO in allograft glomerulitis and capillaritis, not associated with C4d staining. CONCLUSIONS: Intimal arteritis in kidney allograft rejection is composed of a mixed infiltrate of MO and T-lymphocytes. In contrast to MO in PTCitis and glomerulitis, the MO in intimal arteritis are not associated with markers of humoral immune response and there are no different allograft outcomes between MO and T-lymphocyte-dominated groups.
Authors: H Regele; M Exner; B Watschinger; C Wenter; M Wahrmann; C Osterreicher; M D Säemann; N Mersich; W H Hörl; G J Zlabinger; G A Böhmig Journal: Nephrol Dial Transplant Date: 2001-10 Impact factor: 5.992
Authors: K Solez; R B Colvin; L C Racusen; B Sis; P F Halloran; P E Birk; P M Campbell; M Cascalho; A B Collins; A J Demetris; C B Drachenberg; I W Gibson; P C Grimm; M Haas; E Lerut; H Liapis; R B Mannon; P B Marcus; M Mengel; M J Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; J L Platt; P Randhawa; I Roberts; L Salinas-Madriga; D R Salomon; D Seron; M Sheaff; J J Weening Journal: Am J Transplant Date: 2007-03 Impact factor: 8.086
Authors: M Mengel; W Gwinner; A Schwarz; R Bajeski; I Franz; V Bröcker; T Becker; M Neipp; J Klempnauer; H Haller; H Kreipe Journal: Am J Transplant Date: 2007-02 Impact factor: 8.086
Authors: Matthias Lorenz; Heinz Regele; Martin Schillinger; Josef Kletzmayr; Bettina Haidbauer; Kurt Derfler; Wilfred Druml; Georg A Böhmig Journal: Transplantation Date: 2005-03-27 Impact factor: 4.939
Authors: Philip J Matheson; Ian D Dittmer; Brent W Beaumont; Mervyn J Merrilees; Helen L Pilmore Journal: Transplantation Date: 2005-06-27 Impact factor: 4.939
Authors: F Moreso; D Seron; F O'Valle; M Ibernon; M Gomà; M Hueso; J M Cruzado; O Bestard; V Duarte; R García del Moral; J M Grinyó Journal: Am J Transplant Date: 2007-10-19 Impact factor: 8.086
Authors: T Fahim; G A Böhmig; M Exner; N Huttary; H Kerschner; S Kandutsch; D Kerjaschki; A Bramböck; K Nagy-Bojarszky; H Regele Journal: Am J Transplant Date: 2007-02 Impact factor: 8.086
Authors: Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce Journal: Genes Dev Date: 2010-01-15 Impact factor: 11.361
Authors: Samia Q Khan; Lingling Guo; David J Cimbaluk; Hatem Elshabrawy; Mohd Hafeez Faridi; Meenakshi Jolly; James F George; Anupam Agarwal; Vineet Gupta Journal: Front Med (Lausanne) Date: 2014-11-12
Authors: Thierry P P van den Bosch; Nynke M Kannegieter; Dennis A Hesselink; Carla C Baan; Ajda T Rowshani Journal: Front Immunol Date: 2017-02-16 Impact factor: 7.561